Last updated on July 2016

Clinical Trial to Assess the Efficacy and Safety of Combination Therapy of Motireb 5/100 mg in Functional Dyspepsia Patients.


Brief description of study

A phase Ⅲ, multi-center, randomized, double-blinded, placebo and active comparator clinical trial to assess the efficacy and safety of combination therapy of Motireb 5/100 mg in functional dyspepsia patients.

Clinical Study Identifier: NCT02831543

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Nayoung Kim, M.D., Ph.D.

Seoul National University Bundang Hospital
Seong Nam, Korea, Republic of
  Connect »